BREAKING
Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago BrightView Q1 2026 Results: Revenue Beats Expectations but Profitability Challenges Weigh on Stock 2 days ago Fed Signals Potential Rate Cuts Amid Cooling Inflation Data 1 week ago Tech Giants Report Record Q4 Earnings, Beat Wall Street Estimates 1 week ago Oil Prices Surge 5% on Middle East Supply Disruption Fears 1 week ago Major Pharmaceutical Merger Announced: $50B Deal Reshapes Industry 1 week ago Retail Sales Beat Expectations, Consumer Spending Remains Strong 1 week ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago BrightView Q1 2026 Results: Revenue Beats Expectations but Profitability Challenges Weigh on Stock 2 days ago Fed Signals Potential Rate Cuts Amid Cooling Inflation Data 1 week ago Tech Giants Report Record Q4 Earnings, Beat Wall Street Estimates 1 week ago Oil Prices Surge 5% on Middle East Supply Disruption Fears 1 week ago Major Pharmaceutical Merger Announced: $50B Deal Reshapes Industry 1 week ago Retail Sales Beat Expectations, Consumer Spending Remains Strong 1 week ago
ADVERTISEMENT
AlphaGraphs

CME Earnings: Highlights of CME Group’s Q2 2023 report

Derivatives marketplace CME Group Inc. (NASDAQ: CME) on Wednesday reported higher earnings and revenues for the second quarter of 2023. CME Group’s second-quarter revenues increased 10% year-over-year to $1.36 billion, with all three operating segments registering strong growth. Net income, adjusted for one-off items, increased 17% year-over-year to $2.30 per share during the three-month period. […]

July 26, 2023 1 min read

Derivatives marketplace CME Group Inc. (NASDAQ: CME) on Wednesday reported higher earnings and revenues for the second quarter of 2023.

CME Group Q2 2023 earnings infographic

CME Group’s second-quarter revenues increased 10% year-over-year to $1.36 billion, with all three operating segments registering strong growth.

Net income, adjusted for one-off items, increased 17% year-over-year to $2.30 per share during the three-month period. Unadjusted earnings were $767.8 million or $2.14 per share, which is higher than the profit generated in the prior-year period.

“Given ongoing uncertainty in both macroeconomic and geopolitical environments, market participants continued turning to CME Group risk management products and services in Q2, with particularly noteworthy volume increases across our interest rate, commodity, and options contracts,” said CME’s CEO Terry Duffy.

ADVERTISEMENT
ADVERTISEMENT